Literature DB >> 11344128

Dexfenfluramine as a mitogen signal via the formation of superoxide anion.

S L Lee1, W W Wang, B L Fanburg.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11344128     DOI: 10.1096/fj.00-0431fje

Source DB:  PubMed          Journal:  FASEB J        ISSN: 0892-6638            Impact factor:   5.191


× No keyword cloud information.
  12 in total

Review 1.  Transglutaminase 2-mediated serotonylation in pulmonary hypertension.

Authors:  K C Penumatsa; B L Fanburg
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2013-12-27       Impact factor: 5.464

Review 2.  Ontogeny and regulation of the serotonin transporter: providing insights into human disorders.

Authors:  Lynette C Daws; Georgianna G Gould
Journal:  Pharmacol Ther       Date:  2011-04-05       Impact factor: 12.310

3.  Serotonin transporter polymorphisms in familial and idiopathic pulmonary arterial hypertension.

Authors:  Elisabeth D Willers; John H Newman; James E Loyd; Ivan M Robbins; Lisa A Wheeler; Melissa A Prince; Krista C Stanton; Joy A Cogan; James R Runo; Daniel Byrne; Marc Humbert; Gerald Simonneau; Benjamin Sztrymf; Jane A Morse; James A Knowles; Kari E Roberts; Jude J McElroy; Robyn J Barst; John A Phillips
Journal:  Am J Respir Crit Care Med       Date:  2005-12-09       Impact factor: 21.405

4.  Serotonin produces monoamine oxidase-dependent oxidative stress in human heart valves.

Authors:  Ricardo A Peña-Silva; Jordan D Miller; Yi Chu; Donald D Heistad
Journal:  Am J Physiol Heart Circ Physiol       Date:  2009-08-07       Impact factor: 4.733

5.  Serotonylated fibronectin is elevated in pulmonary hypertension.

Authors:  Lin Wei; Rod R Warburton; Ioana R Preston; Kari E Roberts; Suzy A A Comhair; Serpil C Erzurum; Nicholas S Hill; Barry L Fanburg
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2012-04-20       Impact factor: 5.464

6.  Serotonin induces pulmonary artery smooth muscle cell migration.

Authors:  Regina M Day; Abena S Agyeman; Michael J Segel; Rubén D Chévere; Jill M Angelosanto; Yuichiro J Suzuki; Barry L Fanburg
Journal:  Biochem Pharmacol       Date:  2006-01-12       Impact factor: 5.858

Review 7.  Pulmonary hypertension: therapeutic targets within the serotonin system.

Authors:  Y Dempsie; M R MacLean
Journal:  Br J Pharmacol       Date:  2008-06-09       Impact factor: 8.739

Review 8.  Reactive oxygen species in pulmonary vascular remodeling.

Authors:  Saurabh Aggarwal; Christine M Gross; Shruti Sharma; Jeffrey R Fineman; Stephen M Black
Journal:  Compr Physiol       Date:  2013-07       Impact factor: 9.090

9.  A serotonergic system in veins: serotonin transporter-independent uptake.

Authors:  A Elizabeth Linder; Wei Ni; Theodora Szasz; Robert Burnett; Jessica Diaz; Timothy J Geddes; Donald M Kuhn; Stephanie W Watts
Journal:  J Pharmacol Exp Ther       Date:  2008-03-05       Impact factor: 4.030

10.  Dexfenfluramine and the oestrogen-metabolizing enzyme CYP1B1 in the development of pulmonary arterial hypertension.

Authors:  Yvonne Dempsie; Neil A MacRitchie; Kevin White; Ian Morecroft; Audrey F Wright; Margaret Nilsen; Lynn Loughlin; Kirsty M Mair; Margaret R MacLean
Journal:  Cardiovasc Res       Date:  2013-03-20       Impact factor: 10.787

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.